Lovesac (LOVE) Posts Mixed Q2 Results: Sales Up, Net Loss Grows
Lovesac posted modest Q2 sales growth but reported a wider net loss, while reaffirming its plans to strengthen performance in the months ahead.
BTC$61,729.00+3.06%
ETH$1,697.78+5.18%
USDT$0.999+0.01%
USDC$0.9998+0.02%
XRP$1.09+3.07%
SOL$80.81+4.81%
TRX$0.3179+0.03%
FIGR_HELOC$1.03+2.01%
HYPE$65.62+2.25%
DOGE$0.0742+1.83%
RAIN$0.0155-0.48%
USDS$0.9998+0.00%
LEO$9.13-0.91%
ZEC$437.59+6.25%
XLM$0.1997+0.50%
BTC$61,729.00+3.06%
ETH$1,697.78+5.18%
USDT$0.999+0.01%
USDC$0.9998+0.02%
XRP$1.09+3.07%
SOL$80.81+4.81%
TRX$0.3179+0.03%
FIGR_HELOC$1.03+2.01%
HYPE$65.62+2.25%
DOGE$0.0742+1.83%
RAIN$0.0155-0.48%
USDS$0.9998+0.00%
LEO$9.13-0.91%
ZEC$437.59+6.25%
XLM$0.1997+0.50%
Kroger’s strong Q2 performance beat expectations and prompted an upward revision in full-year forecasts.
Lovesac posted modest Q2 sales growth but reported a wider net loss, while reaffirming its plans to strengthen performance in the months ahead.
Apple’s valuation now rests on a delicate balance between financialization and its ability to monetize loyalty.
Synopsys stock crashed over 34% today following disappointing Q3 fiscal 2025 and trade war headwinds.
GameStop beats Q2 expectations with 21.8% revenue growth to $972.2 million and EPS of $0.25, marking a significant turnaround,
Chewy's Q2 2025 results reveal an 8.6% increase in net sales year-over-year, surpassing revenue expectations.
Oracle shares soared nearly 30% in premarket trading after the company projected over $500 billion in cloud infrastructure bookings.
From tariffs to jobs data, U.S. macro trends are tightening the Fed’s bind, fueling gold’s appeal as a safe-haven hedge against the manipulated dollar.
Teck Resources shares surged in premarket trading following announcement of its merger with Anglo American.
SailPoint reported a 33% increase in total revenue for the fiscal second quarter of 2026, surpassing expectations and leading to a raised guidance for the full…
Korn Ferry's first-quarter results for fiscal 2026 demonstrate significant growth, with fee revenue surpassing expectations.
QuantumScape stock jumped over 20% after demonstrating its revolutionary solid-state batteries in a live Ducati motorcycle.
Rapport Therapeutics shares surged in premarket trading after announcing positive Phase 2a trial results for RAP-219, showing 77.8% reduction in clinical seizures.